Kraig Biocraft Laboratories (KBLB) Payables (2010 - 2026)

Kraig Biocraft Laboratories has disclosed Payables across 17 years of filings, most recently posting $10.3 million for Q2 2026.

• In Q2 2026, Payables rose 8.98% year-over-year to $10.3 million; the TTM figure through Jun 2026 stood at $10.3 million (up 8.98% YoY), while the FY2025 annual figure was $9.8 million, up 9.14% from the prior year.
• Payables came in at $10.3 million for Q2 2026 at Kraig Biocraft Laboratories, up from $9.8 million in the prior quarter.
• In the past five years, Payables ranged from a high of $10.3 million in Q2 2026 to a low of $2.1 million in Q2 2023.
• Average Payables over 5 years is $6.6 million, with a median of $8.3 million recorded in 2024.
• Year-over-year, Payables retreated 6.29% in 2023 and jumped 296.37% in 2024.
• Over 5 years, Payables stood at $2.2 million in 2022, then surged by 280.17% to $8.2 million in 2023, then gained by 9.74% to $9.0 million in 2024, then advanced by 9.14% to $9.8 million in 2025, then rose by 4.44% to $10.3 million in 2026.
• Per Business Quant data, the three most recent Payables figures were $10.3 million in Q2 2026, $9.8 million in Q4 2025, and $9.6 million in Q3 2025.